Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 2005, p. 804-807, Vol. 49, No. 2
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.2.804-807.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya,1 Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan2
Received 4 May 2004/ Returned for modification 5 August 2004/ Accepted 11 October 2004
A simple fibroblast-based assay (SFA) was found to be efficient in evaluating the susceptibilities of clinical isolates of Mycobacterium tuberculosis to pyrazinamide (PZA). Forty-five clinical isolates were examined. The MICs of PZA for susceptible strains in an SFA were between 3.13 and 12.5 µg/ml, and the MICs of PZA for resistant strains were more than 100 µg/ml.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»